Search

Background: Intraocular lenses with a negative aspherical design for correction of corneal spherical aberration (SA) have gained popularity in recent decades. In most cases, a 'one size fits all' concept is followed, where all eyes receive lenses with the same SA correction. The purpose of this study is to develop a strategy based on raytracing using anterior segment tomography data to extract corneal SA and to provide simple multivariable linear models for prediction of corneal SA., Methods: The analysis was based on a large dataset of 8737 measurements of 8737 eyes from 1 clinical centre, using the Casia2 anterior segment tomographer. An optical model based on: corneal front and back surface radius Ra and Rp, asphericities Qa and Qp, corneal thickness CCT, anterior chamber depth ACD, and pupil centre position (X-Y position: Pup X and Pup Y ), was defined for each measurement. Corneal SA was derived using a 6-mm aperture perpendicular to the incident ray and centred on the chief ray, and linear prediction models were derived for SA using biometric data. Cross-validation was used for model performance evaluation., Results: Using raytracing, the wavefront error within an aperture (6-mm diameter centred on the intersection of the chief ray with the cornea) was calculated and corneal SA was extracted. After identifying the relevant effect sizes (Ra, Qa, Rp Qp, ACD, Pup X and Pup Y ) using stepwise linear regression, linear mixed-effects models (model 1: all effect sizes, model 2: Ra, Qa, Rp and Qp, model 3: Ra and Qa) were set up on the training data in terms of a Monte-Carlo simulation. On the test data (training data), model 1 with a mean absolute/root-mean-squared prediction error of 0.0095/0.0130 (0.0095/0.0127) performed similarly to model 2 with 0.0097/0.0131 (0.0096/0.0127), and both outperformed model3 with 0.0152/0.0197 (0.0148/0.0190)., Conclusion: Based on the Casia2 anterior segment tomographer, corneal SA could be derived using shape data (curvature and asphericities) of both corneal surfaces (model 2). This information could easily be used for selection of the appropriate negative aspherical lens design in cataract surgery., (© 2022 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.)

Objective: To assess the relative efficacy of methotrexate (MTX), azathioprine (AZA), and their combination in the treatment of rheumatoid arthritis (RA) in a double-blind, prospective, multicenter, controlled trial., Methods: Two hundred nine patients with active RA were treated with escalating doses of MTX (5-15 mg/week), AZA (50-150 mg/day), or combination (5mg MTX/week plus 50 mg AZA/day-7.5 mg MTX/week plus 100 mg AZA/day), with opportunity to increase the dosage at 6-week intervals. The patients were evaluated for significant clinical and laboratory improvement and assessed for radiologic progression at 48 weeks., Results: One hundred ten patients remained on the initial, randomly assigned therapeutic regimen. The percentage of patients who were responders, defined as those who had 30% or greater improvement in at least 3 of 4 variables, was 38% for the combination treatment, 26% for AZA, and 45% for MTX (P = 0.06). A trend toward decreased radiologic progression was seen in the MTX-treated patients. Termination of treatment due to adverse experience occurred more frequently with combination and AZA treatments than with MTX treatment. Lack of effectiveness, adverse gastrointestinal effects, and liver enzyme elevation were the most frequent causes of treatment discontinuation., Conclusion: This study establishes that the combination of MTX and AZA in the dosages utilized is not associated with more toxicity than treatment with single agents; however, enhanced efficacy is also not seen. There is a trend toward decreased radiologic progression in patients treated with MTX.